Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection
PHASE2
The purpose of this open-label study is to assess the safety, tolerability,...
Status
Unknown
Location
The Liver Institute at Methodist Dallas Medical Center
Long Term Extension Study is Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 Infection
N/A
Long Term Observational Extension Study Designed to Monitor Long-Term Effic...
Status
Completed
Location
Methodist Transplant Physicians
Start Date
2014-05-07
Trial ID
NCT02452814
Safety Study of SPC3649 in Healthy Men
PHASE1
A placebo-controlled, double-blind, randomized, single dose, dose escalatin...
Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin
N/A
Genotype 1 CHC participants from Study SPC3649-207 with null response to pr...
Status
Completed
Location
Fundacion de Investigacion de Diego
Start Date
2013-08-02
Trial ID
NCT02508090
Multiple Ascending Dose Study of Miravirsen in Treatment-NaΓ―ve Chronic Hepatitis C Subjects
PHASE2
The main purpose of this study is to determine the safety and tolerability ...